Home | Welcome to Contract Pharma   
Last Updated Sunday, November 23 2014
Print RSS Feed

Financial Report: PAREXEL



Published May 1, 2013
PAREXEL

3Q Revenues: $523.5 million (+27%)

3Q Earnings: $29.5 million (+29%)

YTD Revenues: $1.5 billion (+27%)

YTD Earnings: $65.9 million (+45%)

Comments: Clinical Research Services (CRS) revenues were $342.4 million in the quarter, up 30%. PAREXEL Consulting & Medical Communications Services (PCMS) revenues were $50.6 million, up 17%. Perceptive Informatics (PI) revenues were $61.5 million, up 25%.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On